ArticleBreast cancer research : BCR2011

Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer.

Ali Naderi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.